WallStreetZenWallStreetZen

NASDAQ: HRMY
Harmony Biosciences Holdings Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HRMY past earnings growth

How has HRMY's earnings growth performed historically?
Company
-29.32%
Industry
52.08%
Market
61.16%
HRMY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HRMY's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

HRMY past revenue growth

How has HRMY's revenue growth performed historically?
Company
32.93%
Industry
148.4%
Market
16.96%
HRMY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HRMY's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HRMY's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HRMY earnings and revenue history

Current Revenue
$582.0M
Current Earnings
$128.9M
Current Profit Margin
22.1%

HRMY Return on Equity

Current Company
27.5%
Current Industry
-63.5%
Current Market
188%
HRMY's Return on Equity (27.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HRMY announces earnings.

HRMY Return on Assets

Current Company
16.8%
Current Industry
2.9%
HRMY is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HRMY Return on Capital Employed

Current Company
30.44%
Current Industry
19.5%
HRMY has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HRMY vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HRMY$582.02M$221.51M$128.85M+213.90%+90.18%
INBX$1.80M-$206.56M-$241.36M-26.85%N/A
GPCR$0.00-$88.46M-$89.62MN/AN/A
ZLAB$266.72M-$316.88M-$334.62M+360.35%N/A
SNDX$0.00-$208.40M-$209.36M-100.00%N/A
View Top Biotech Stocks

HRMY earnings dates

Next earnings date
May 29, 2024

Harmony Biosciences Holdings Earnings & Revenue FAQ

What were HRMY's earnings last quarter?

On Invalid Date, Harmony Biosciences Holdings (NASDAQ: HRMY) reported Q4 2023 earnings per share (EPS) of $0.46, up 43.9% year over year. Total Harmony Biosciences Holdings earnings for the quarter were $26.61 million. In the same quarter last year, Harmony Biosciences Holdings's earnings per share (EPS) was $0.82.

If you're new to stock investing, here's how to buy Harmony Biosciences Holdings stock.

What was HRMY's earnings growth in the past year?

As of Q2 2024, Harmony Biosciences Holdings's earnings has grown -29.32% year over year. This is 81.39 percentage points lower than the US Biotechnology industry earnings growth rate of 52.08%. Harmony Biosciences Holdings's earnings in the past year totalled $128.85 million.

What is HRMY's earnings date?

Harmony Biosciences Holdings's earnings date is Invalid Date. Add HRMY to your watchlist to be reminded of HRMY's next earnings announcement.

What was HRMY's revenue last quarter?

On Invalid Date, Harmony Biosciences Holdings (NASDAQ: HRMY) reported Q4 2023 revenue of $168.41 million up 31.26% year over year. In the same quarter last year, Harmony Biosciences Holdings's revenue was $128.31 million.

What was HRMY's revenue growth in the past year?

As of Q2 2024, Harmony Biosciences Holdings's revenue has grown 32.93% year over year. This is 115.48 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Harmony Biosciences Holdings's revenue in the past year totalled $582.02 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.